We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Abingdon Health Plc | LSE:ABDX | London | Ordinary Share | GB00BLF79J41 | ORD 0.025P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.25 | -2.27% | 10.75 | 10.50 | 11.00 | 11.00 | 10.75 | 11.00 | 254,830 | 13:25:41 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Chemicals & Chem Preps, Nec | 4.05M | -3.45M | -0.0284 | -3.87 | 13.39M |
Date | Subject | Author | Discuss |
---|---|---|---|
03/1/2021 08:39 | What happens if MHRA do not approve the home test when the Supply of Goods Contract ends on 14th February 2021?Will they concentrate on US and India ? | oapknob1 | |
30/12/2020 14:39 | We know that the ABC-19 Antibody tests are linked to AZ/Oxford Vaccine.. | barrywhit | |
30/12/2020 13:48 | barrywhit I cannot see any reference to the AbC-19 Test on the Twitter comment you have posted but the approval by MHRA of the Oxford A-Z vaccine is certainly wonderful news for everyone. Being an optimist I hope that the delay by MHRA in approving the use of the AbC test for domestic use may have been caused in part by priority rightly given to the vaccine and that good news may emerge soon from them on this test. Lennonsative Which lateral flow test is being used at schools ? Given the huge number of candidates for testing, are several different makes of test being used ? Is AbC-19 one of them ? It seems odd that ABDX has chosen the Maltese Medicine Authority for registration but I dare say that the MMA has high standing in this field. If the product is indeed authorised for professional use through the EU, then authorisation for domestic use may soon follow. | varies | |
30/12/2020 08:46 | Good news for the ABC-19 Test... | barrywhit | |
29/12/2020 12:20 | What does today's announcement mean, anyone know ? Have they lost a contract ? or is everything tickety boo ? | gfrae | |
18/12/2020 11:06 | Just a bit of information The Government have announced that rapid ‘lateral flow’ testing should be available in schools and colleges – for staff and students - from January | lennonsalive | |
15/12/2020 10:38 | no more needs to be said! | jusjusjus | |
15/12/2020 10:31 | This will be sub placing price soon like odx | justtrying1 | |
15/12/2020 10:01 | >>>JusJus N+1 Singer are the corporate Broker and also one of the market makers | timbo003 | |
15/12/2020 09:53 | may I ask a question on the mechanics, is a market maker(s) working on behalf of the house broker to sell the float to the market? | jusjusjus | |
15/12/2020 09:46 | II TAKING TELEPHONE ORDERS AND PAY WEB CHARGE | scoble2 | |
15/12/2020 09:02 | still no response from ii | scoble2 | |
15/12/2020 08:56 | For info: Halifax sharedealing are quoting 104.5p to buy | timbo003 | |
15/12/2020 08:55 | can't buy ii | scoble2 | |
15/12/2020 08:13 | can't buy from ii | scoble2 | |
15/12/2020 08:12 | Currently 105 - 110p with 58K shares traded | timbo003 | |
15/12/2020 08:09 | whats it opened at, cant trade on ii.co.uk. | latifs100 | |
15/12/2020 07:41 | First day of dealing today I mananged to pick up a few EIS qualifying shares in the IPO, but application was scaled back by about 65% | timbo003 | |
15/12/2020 07:31 | First day of trading (December 15th 2020) * Issue price – 96p * Capital to be raised on admission - £22.0m * Anticipated mkt cap. – £91.9m * % of shares not in public hands – 67.9% Established in 2008, Abingdon Health is a lateral flow diagnostics company providing contract service solutions to a global client base in the healthcare sector and other industries. Services offered by the Company to its clients including product development, regulatory support, technology transfer and commercial manufacturing. The Company has developed and is manufacturing the AbC-19TM Rapid Test, an antibody test for Covid-19 indicating whether a person is generating IgG antibodies to the spike protein of the SARS-CoV-2 virus. The Company is also working with three customers to transfer their Covid-19 antigen tests to manufacture, and is manufacturing a component of a rapid PCR (polymerase chain reaction) test. The Company also produces lateral flow tests covering non-Covid-19 applications in areas such as self-test HIV, equine infection, human fertility, blood cancer and other infectious diseases across the healthcare sector as well as other areas such as fuel contamination in the aviation sector and testing for water contaminants. Useful Links: | timbo003 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions